logo

For the Inventor, By the Inventor

Burlington, Canada

David A Clark

This inventor holds 12 USPTO granted patents and 1 published patent application. Top assignees: Trillium Therapeutics Inc., Mcmaster University, Transplantation Technologies Inc.. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Clark. Retrieved from https://idiyas.com/inventor/david-a-clark-f8fn9u36

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 16.7

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 157(Granted Patents)


Company Filing History:

goldMedal10 out of 29 
 
Trillium Therapeutics Inc.
 patents
silverMedal1 out of 272 
 
Mcmaster University
 patents
bronzeMedal1 out of 2 
 
Transplantation Technologies Inc.
 patents

Years Active: 2002-2023

Loading Chart...
12 patents (USPTO):Explore Patents
1. 11719707 - Methods for the diagnosis and treatment of endometriosis (2023-08-08),
2. 8187598 - Methods of treating cancer by administering antibodies to CD200 (2012-05-29),
3. 7902151 - Methods and compositions for modulating immunity (2011-03-08),
4. 7887798 - Methods of treating cancer by administering antibodies to CD200 (2011-02-15),
5. 7553811 - Methods and compositions for modulating immunity (2009-06-30),
6. 7452536 - Methods of treating cancer by administering antibodies to CD200 (2008-11-18),
7. 7291330 - MD-1 inhibitors as immune suppressants (2007-11-06),
8. 7238352 - Methods and compositions for modulating tumor growth (2007-07-03),
9. 6955811 - Methods of inhibiting immune response suppression by administering antibodies to OX-2 (2005-10-18),
10. 6749854 - Use of OX-2 to inhibit fetal loss (2004-06-15),
11. 6652858 - Use of OX-2 to suppress an immune response (2003-11-25),
12. 6403089 - Methods of modulating immune coagulation (2002-06-11),

Title: The Innovative Contributions of David A. Clark

Introduction

David A. Clark is a prominent inventor based in Burlington, CA, known for his significant contributions to medical science. With a total of 12 patents to his name, he has made remarkable strides in the fields of diagnostics and treatment methodologies.

Latest Patents

Among his latest patents, Clark has developed methods for the diagnosis and treatment of endometriosis. This invention focuses on detecting CD200L in a female subject from a secretory phase biological sample. Increased levels of CD200L have been associated with endometriosis, making it a valuable biomarker for diagnosis and a target for therapeutic intervention. Additionally, he has patented methods for treating cancer by administering antibodies to CD200. These methods involve regulating immunity, where agents that inhibit OX-2 are administered to enhance immune responses, proving useful in cancer treatment.

Career Highlights

Throughout his career, David A. Clark has worked with notable companies such as Trillium Therapeutics Inc. and Transplantation Technologies Inc. His innovative work has positioned him as a key figure in the development of new medical treatments.

Collaborations

Clark has collaborated with esteemed colleagues, including Reginald M. Gorczynski and Gary Levy, further enhancing the impact of his research and inventions.

Conclusion

David A. Clark's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in diagnostics and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…